A detailed history of Ieq Capital, LLC transactions in Incyte Corp stock. As of the latest transaction made, Ieq Capital, LLC holds 138,536 shares of INCY stock, worth $10.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
138,536
Previous 9,604 1342.48%
Holding current value
$10.3 Million
Previous $634,000 1409.15%
% of portfolio
0.09%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$65.08 - $83.38 $8.39 Million - $10.8 Million
128,932 Added 1342.48%
138,536 $9.57 Million
Q3 2024

Nov 14, 2024

SELL
$57.33 - $68.61 $83,472 - $99,896
-1,456 Reduced 13.16%
9,604 $634,000
Q2 2024

Aug 12, 2024

BUY
$51.18 - $63.75 $180,716 - $225,101
3,531 Added 46.9%
11,060 $670,000
Q1 2024

May 08, 2024

BUY
$56.55 - $66.59 $31,159 - $36,691
551 Added 7.9%
7,529 $428,000
Q4 2023

Feb 07, 2024

BUY
$52.16 - $64.19 $33,486 - $41,209
642 Added 10.13%
6,978 $438,000
Q3 2023

Nov 03, 2023

BUY
$57.77 - $65.93 $75,736 - $86,434
1,311 Added 26.09%
6,336 $366,000
Q2 2023

Aug 07, 2023

SELL
$60.95 - $75.51 $192,967 - $239,064
-3,166 Reduced 38.65%
5,025 $312,000
Q1 2023

May 01, 2023

BUY
$70.23 - $86.01 $198,891 - $243,580
2,832 Added 52.85%
8,191 $591,000
Q4 2022

Feb 03, 2023

SELL
$67.18 - $84.11 $138,189 - $173,014
-2,057 Reduced 27.74%
5,359 $430,000
Q3 2022

Nov 03, 2022

SELL
$66.18 - $82.86 $37,590 - $47,064
-568 Reduced 7.11%
7,416 $494,000
Q2 2022

Jul 27, 2022

SELL
$66.18 - $83.18 $3,375 - $4,242
-51 Reduced 0.63%
7,984 $607,000
Q1 2022

Apr 26, 2022

BUY
$66.02 - $79.71 $88,136 - $106,412
1,335 Added 19.93%
8,035 $638,000
Q4 2021

Jan 31, 2022

BUY
$63.34 - $74.11 $209,402 - $245,007
3,306 Added 97.41%
6,700 $492,000
Q3 2021

Nov 09, 2021

BUY
$68.67 - $84.02 $11,330 - $13,863
165 Added 5.11%
3,394 $234,000
Q2 2021

Jul 29, 2021

BUY
$79.87 - $87.53 $39,375 - $43,152
493 Added 18.02%
3,229 $272,000
Q1 2021

May 04, 2021

BUY
$76.02 - $100.5 $207,990 - $274,968
2,736 New
2,736 $222,000
Q4 2020

Feb 03, 2021

SELL
$80.74 - $97.7 $199,266 - $241,123
-2,468 Closed
0 $0
Q3 2020

Nov 03, 2020

BUY
$85.07 - $109.69 $43,811 - $56,490
515 Added 26.37%
2,468 $221,000
Q2 2020

Jul 31, 2020

BUY
$74.18 - $108.93 $144,873 - $212,740
1,953 New
1,953 $203,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.